NCT00925535View on ClinicalTrials.gov

Drug Interaction Study Between Rifabutin And Lersivirine (UK-453,061)

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions

Healthy Volunteers

Interventions

DRUG

Lersivirine

1000 mg once daily for 10 days

DRUG

Rifabutin

300 mg once daily for 10 days

DRUG

Lersivirine

1000 mg once daily for 10 days

DRUG

Rifabutin

300 mg once daily for 10 days

Trial Locations (1)

188770

Pfizer Investigational Site, Singapore

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY